A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine

British Journal of Pharmacology

Volumn 134, Issue 1, 2001, Pages 215-223

  Lördal, Mikael ^a   Navalesi, Giovanni ^b   Theodorsson, Elvar ^c   Maggi, Carlo A ^b   Hellström, Per M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Menarini Ricerche SpA   (Italy)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Duodeno jejunal motility; Human; Neuropeptide

Indexed keywords

NEPADUTANT; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG TOLERANCE; DUODENUM MOTILITY; ELECTROCARDIOGRAM; HUMAN; INTESTINE INNERVATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034840435     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704217     Document Type: Article

References (36)

1. Substance P and 5-HT in granules isolated from an intestinal argentaffin carcinoid
2. Search for a physiological role of substance P in gastrointestinal motility
3. Neurokinin-I (NK-I) receptor is required in Clostridium difficile-induced enteritis
4. MEN 11420 (Nepadutant) a novel glycosylated bicyclic peptide tachykinin NK-2 receptor antagonist
5. 2 in transfected chinese hamster ovary cells
6. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors
7. Substance P receptor antagonist (FK 888) modifies gut alterations induced by ionizing radiation
8. Substance P in tumors: Pheochromocytoma and carcinoid
9. NK-2 tachykinin receptors and contraction of circular muscle of the human colon: Characterization of the NK-2 receptor subtype
10. Implications of tachykinins and calcitonin generelated peptide in inflammatory bowel disease
11. Tachykinins in the gut. Part I. Expression, release and motor function
12. Tachykinin NK1 and NK2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro
13. Identification of mechanisms for duodenal contraction induced by tachykinins in the rat
14. 2 receptor antagonist MEN 11420 (nepadutant) in rats
15. Myoelectric pattern and effects on small bowel transit induced by the tachykinins neurokinin A, neurokinin B, substance P and neuropeptide K in the rat
16. Tachykinins influence interdigestive rhytm and contractile strength of human small intestine
17. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat
18. The tachykinins neurokinin A and substance P, but not neurokinin B stimulate contraction of isolated muscle cells from rat small intestine
19. Human isolated small intestine: Motor responses of the longitudinal muscle to field stimulation and exogenous neuropeptides
20. Tachykinin receptors in the circular muscle of the guinea-pig ileum
21. Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum
22. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon
23. Effects of tachykinin receptor antagonists on the rat jejunal distension pain response
24. Tachykinins in carcinoid tumors: Their use as a tumor marker and possible role in the carcinoid flush
25. Polypeptide hormone production by "carcinoid" apudomas and their relevant cytochemistry
26. Substance P receptor expression in intestinal epithelium in clostridium difficile toxin A enteritis in rats
27. Intestinal motility responses to neuropeptide gamma in vitro and in vivo in the rat: Comparison with neurokinin 1 and neurokinin 2 receptor agonists
28. Substance P in the argentaffin carcinoid of the caecum: Biochemical and biological characterization
29. Pharmacology of neurokinin receptors
30. Substance P secretion by carcinoid tumours
31. Contractile responses of rat duodenum caused by transmural nerve stimulation: Interaction between tachykininergic and cholinergic mechanisms
32. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine
33. Substance P containing nerve fibers in ulcerative colitis
34. Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours
35. Enteroglucagon and substance P-like immunoreactivity in argentaffin and argyrophil rectal carcinoids
36. 2 receptors mediate NANC excitatory neuromuscular transmission in the human ileum